Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Reliv International Inc RELV

Reliv' International, Inc. is a developer and marketer of a line of nutritional supplements addressing basic nutrition, specific wellness needs, weight management and sports nutrition. The Company sells its products through an international network marketing system using independent distributors. The Company operates through a network marketing segment consisting of six operating units that sell nutritional and dietary products to a sales force of independent distributors that sell the products directly to customers. Its products include Reliv Now with Soy; FibRestore; Innergize! Go; LunaRich; ReversAge; Reliv Now for Kids; Arthaffect; ProVantage; SoySentials; CardioSentials; Reliv Defense; RLV Hemp Full Spectrum 750, and others. Its geographic region includes the United States, Australia/New Zealand, Canada, Mexico, Europe and Asia. Its subsidiaries include Reliv, Inc., Reliv World Corporation, Reliv Australia Pty, Limited, Reliv Now de Mexico, S. de R.L. de C.V. and others.


OTCPK:RELV - Post by User

Post by investorblingon Feb 07, 2007 12:57pm
192 Views
Post# 12180447

Recommendations for February 7, 2007

Recommendations for February 7, 2007

The Bomb

No update today for some reason. :(

Concorde

Aspen Technology | Dennis C. Wassung, Jr., CFA, AZPN : NNM : US$10.29 | US$946.7M | Buy, Target US$15.00

Q2 blowout, raising estimates

Bankrate | Colin Gillis, RATE : NNM : US$44.47 | US$867.7M | Buy, Target US$50.00

Healthy DecQ results; lead generation next major driver

Business Objects | Peter Misek, BOBJ : NNM : US$38.88 | US$3.762.7M | Speculative Buy, Target US$45.00

Strong fundamentals persist

CAE Inc. | Robert Fay, CAE : TSX : C$11.65 | C$2,924.2M | CGT : NYSE : US$9.82 | Sell, Target C$8.00

CAE Q3/07 preview

Calpine Power Income Fund | Bob Hastings, CF.UN : TSX : C$13.26 | C$818.7M | Hold, Target C$13.50

Another bid?

Cumberland Resources Ltd. | Graeme Currie, CLG : TSX : $7.18 | C$540.7M | Hold, Target C$7.25

Target price reached

MIGENIX Inc. | Neil Maruoka, MGI : TSX : $0.66 | C$62.0M | Buy, Target C$1.50

Prospective partner Schering drops the ball

Metal Management | Eric Glover, CFA, MM : NYSE : US$40.82 | US$1.065.4M | Buy, Target US$48.00

DecQ results mixed, but outlook strong: Raising estimates and setting new $48 target price

PDF Solutions | Dennis C. Wassung, Jr., CFA, PDFS : NNM : US$11.07 | US$345.3M | Buy, Target US$15.00

Strong guidance after tough Q4

Reliv International | Scott Van Winkle, CFA, RELV : NNM : US$10.44 | US$178.0M | Buy, Target US$12.00

Timely and comprehensive launch

Select Comfort | Stephen Colbert, SCSS : NNM : US$18.67 | US$1,032.5M | Hold, Target US$17.00

Expect in-line Q4 results; F2007 guidance concerns remain

USANA Health Sciences | Scott Van Winkle, CFA, USNA : NNM : US$54.63 | US$1,031.5M | Hold, Target US$58.00

Healthy growth, healthy outlook

Verenex Energy Inc. | Richard Wyman, VNX : TSX : C$8.90 | C$321.2M | Hold , Target C$8.30

Stock ahead on exploration activity in Libya -- Valuation revised

<< Previous
Bullboard Posts
Next >>